治疗慢性胰腺炎的口服印米他辛:PAIR随机化安慰剂对照试验的结果
Samuel Han1, Santhi Swaroop Vege1, Phil A Hart2
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Clinical and translational gastroenterology
|July 7, 2025
概括
慢性胰腺炎 (CP) 的治疗方法印米他被发现是安全的,但没有显著降低前列腺素E2 (PGE2) 水平. 需要进一步的研究,以探索其对炎症的影响和CP患者的治疗结果.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 炎症研究 炎症研究
背景情况:
- 慢性胰腺炎 (CP) 存在管理挑战,治疗选择有限.
- 前列腺素E2 (PGE2) 已与胰腺的慢性炎症过程有关.
- 研究环氧基因酶-2 抑制剂,如印米他辛,为CP提供了潜在的治疗途径.
研究的目的:
- 评估印莫他辛在降低慢性胰腺炎 (CP) 患者的前列腺素E2 (PGE2) 水平方面的疗效.
- 评估 CP 患者口服印梅他辛的安全性和耐受性.
- 探索印米他辛对CP患者疼痛和生活质量的影响.
主要方法:
- 一项试点多中心随机对照试验,涉及27名CP患者.
- 参与者在28天内每天两次接受口服印梅他辛 (50毫克) 或安慰剂.
- 在胰腺液,血和唾液中测量了PGE2水平,并对疼痛和生活质量进行了评估.
主要成果:
- 印米他辛治疗导致胰腺液,血和唾液中的PGE2水平降低,但与安慰剂相比,这种差异在统计学上并不显著.
- 综合疼痛严重程度得分没有显著改善.
- 在疼痛干扰得分的改善方面,发现了显著性的趋势.
结论:
- 口服印梅他辛在慢性胰腺炎患者中是安全的,并且耐受性很好.
- 这项研究没有显示PGE2水平与印梅他辛治疗显著降低.
- 需要进一步的研究,以阐明印米他在CP的炎症途径和患者报告的结果中的作用.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
131
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
131
01:24Chronic Pancreatitis I: Introduction
166
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
166
01:30Acute Pancreatitis II: Clinical Manifestations and Management
184
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
184
01:27Acute Pancreatitis I: Introduction
496
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
496
01:29Inflammatory Bowel Disease IV: Pharmacological Management
200
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
200
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
275
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
275